http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014063752-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
filingDate 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49e1cc8fd3907e530fe05464784a4e38
publicationDate 2014-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014063752-A1
titleOfInvention Process for making crystalline form alpha of eletriptan hydrobromide
abstract The present invention relates to a process for making the crystalline Form α of eletriptan hydrobromide comprising cooling a solution of eletriptan hydrobromide in ethanol, in the absence of any other organic solvent, from an elevated temperature to ambient or a lower than ambient temperature.
priorityDate 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011089614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012004811-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0032589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9606842-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011004391-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9206973-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008137134-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005020663-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226655669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227057198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9891365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128979847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23623894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49857984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228281856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396047

Total number of triples: 57.